TGC is an open-access, international peer-reviewed journal with a focus on cutting-edge findings in this rapidly changing field, while providing practical up-to-date information on diagnosis, prevention, and treatment of gastrointestinal cancers. It is published quarterly (Apr. 2012- Oct. 2014), bimonthly (Jan. 2015 -) and openly distributed worldwide.
Society for Translational Medicine (STM), Hong Kong, is an international, peer-reviewed Open Access journal featuring original and observational investigations in the broad fields of laboratory, clinical, and public health research, aiming to provide practical up-to-date information in significant research from all subspecialties of medicine and to broaden the readers’ vision and horizon from bench to bed and bed to bench. It is published quarterly (April 2013- Dec. 2013), monthly (Jan. 2014 - Feb. 2015), biweekly (March 2015-) and openly distributed worldwide.
Annals of Translational Medicine is indexed in PubMed in Sept 2014. Specific areas of interest include, but not limited to, multimodality therapy, epidemiology, biomarkers, imaging, biology, pathology, and technical advances related to medicine. Submissions describing preclinical research with potential for application to human disease, and studies describing research obtained from preliminary human experimentation with potential to further the understanding of biological mechanism underlying disease are encouraged. Also warmly welcome are studies describing public health research pertinent to clinic, disease diagnosis and prevention, or healthcare policy.
With a focus on interdisciplinary academic cooperation, ATM aims to expedite the translation of scientific discovery into new or improved standards of management and health outcomes practice.
Submission Turnaround Time:
• Submission to First Editorial Decision: 3-5 days.
• Acceptance to Publication Ahead of Print: 20 days.
• Acceptance to Publication: 1-3 months. Original Articles are listed as priority.
ATM is endorsed by the Bonnie J. Addario Lung Cancer Foundation (ALCF), the Ming-Yi Medical Charity Foundation of Guangdong Province and the international Inspire2Live Patient Advocates organization.
Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; www.thetcr.org), the official publication of
Society for Translational Medicine (STM), is an Open Access, peer-reviewed journal, published by AME Publishing Company, publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. TCR will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving cancer patients' lives. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. TCR was indexed in Science Citation Index Expanded (SCIE).
GlandSurgery (Gland Surg; Print ISSN 2227-684X; Online ISSN 2227-8575), the officialpublication of
Society for Translational Medicine (STM), publishes articles that describe new findings in the field oftranslational research in gland surgery, provides current and practicalinformation on diagnosis, prevention and clinical investigations of glandsurgery. Specific areas of interest include, but not limited to, multimodalitytherapy, biomarkers, imaging, biology, pathology, and technical advances relatedto gland disease (breast, thyroid, digestive gland, et al.). Contributionspertinent to gland surgery are also included from related fields such asnutrition, public health, human genetics, basic sciences, education, sociology,and nursing. The aim of the Journal is to provide a forum for the disseminationof original research articles as well as review articles in all areas relatedto gland disease. It is an international, peer-reviewed journal with a focus oncutting-edge findings in this rapidly changing field, while providing practicalup-to-date information on diagnosis, prevention, and treatment of glanddisease. The journal features a distinguished editorial board, which bringstogether a team of highly experienced specialists in gland disease treatmentand research. The diverse experience of the board members allows our editorialpanel to lend their expertise to a broad spectrum of gland disease subjects.The entire submission and review process are managed through OJS system, anelectronic system, which provides an efficient way and ensures a rapidturnaround of papers submitted for publication.